We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
424 result(s) found, displaying 111 to 120
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: tafenoquine succinate.
-
Prescription medicine decision summaryTGA decision: Jemperli (dostarlimab) is approved to treat patients with recurrent or advanced mismatch repair deficient endometrial cancer.
-
Prescription medicine registrationActive ingredients: dostarlimab.
-
Prescription medicine registrationActive ingredients: mepolizumab.
-
Prescription medicine registrationActive ingredients: mepolizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DOUBLUTS dutasteride 500 microgram and tamsulosin hydrochloride 400 microgram modified release capsule bottle.
-
Prescription medicine registrationActive ingredients: recombinant Varicella Zoster Virus glycoprotein E antigen.